“Chiney”这个英文henry英文名什么意思思

Abstract: The Effect Of Sterculic Oil Intervention On Drug Metabolism Enzyme Activity And Transporter Expression In LETO/OLETF Model Of Obesity (17th North American Regional ISSX Meeting (October 16 - 20, 2011))
The Effect Of Sterculic Oil Intervention On Drug Metabolism Enzyme Activity And Transporter Expression In LETO/OLETF Model Of Obesity
Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN
Harrison Tam
Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN
Laura C. Ortinau
Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO
James W. Perfield II
Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO
L'Aurelle Anna Lee Johnson
Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN
Previous in vitro studies have shown that metabolic syndrome associated ectopic lipid accumulation regulates the expression and activity of drug metabolizing enzymes (DME) and transporters (1, 2).& The lipogenic enzyme stearoyl-CoA desaturase-1 (SCD1) is associated with ectopic lipid deposition and has emerged as a target for the treatment of the metabolic syndrome.& Sterculic oil (SO) is a known natural inhibitor of SCD1 and we hypothesized that SO supplementation would alter obesity-associated changes in DME and transporter expression and activity.& Therefore, the current study examines the role of SO treatment on expression and activity of DME and transporters in lean LETO and obese OLETF rats. Liver tissue samples were isolated from 14 week old male LETO and OLETF rats fed with a standard AIN-93G diet or OLETF animals that were fed an AIN-93G diet supplemented with 0.5% SO (OLETF-SO).& Microsomes were isolated from the livers using a previously described method, while RNA was isolated using a Qiagene& RNA isolation kit. CYP1A, NAT and XO activity was determined using Ethoxyresorufin, p-aminobenzoic acid as probe substrates and Cayman& XO assay kit respectively. The mRNA expression was determined using qRT-PCR. Our results indicate that the hepatic XO activity was 2.5 times higher in the OLETF obese rats when compared to the LETO lean rats (891.2 units/mg vs. 374.8 units/mg protein). The addition of SO to the diets of OLETF rats resulted in significant reversal of the elevated XO activity (450.4 units/mg protein) similar to that of the LETO lean rats.& The hepatic mRNA expression of SLCO1A4 and ABCC2 transporters was 5 and 2.5 fold lower in the OLETF rats when compared to lean LETO rats, (p& 0.001, 0.01) however, this effect was not reversed in the OLETF-SO rats. Interestingly OLETF rats fed an AIN-93G diet supplemented with SO showed an increase in hepatic mRNA expression of ABCB1 (2.5 fold, p & 0.01) and SLC22A6 (1.63 p & 0.05) as compared to the OLETF and LETO rats. No differences were observed between LETO, OLETF, and OLETF-SO rats with respect to hepatic CYP1A and NAT enzyme activity and hepatic ABCC1 and SLC22A6 mRNA levels.& In conclusion, this study demonstrates that inhibition of SCD1 by SO reverses the upregulation of XO activity.& Also SO was found to differentially alter transporter mRNA expression levels. Additional studies are required to determine the exact mechanism of the SO mediated alterations and its role in affecting the disposition of drugs. References
1. Hirunpanich V, Sethabouppha B, Sato H. Inhibitory effects of saturated and polyunsaturated fatty acids on the cytochrome P450 3A activity in rat liver microsomes. Biol Pharm Bull. ):1586-8.
2. Zangar RC, Novak RF. Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes. Arch Biochem Biophys. 1997 Jan 15;337(2):217-24.
Next Abstract

我要回帖

更多关于 意思的英文 的文章

 

随机推荐